Recce Pharmaceuticals Ltd (RCE.AX)
AUD 0.45
(-3.23%)
AUD 0.45
(-3.23%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -21.35 Million AUD | -25.7% |
| 2023 | -16.98 Million AUD | -22.53% |
| 2022 | -10.79 Million AUD | 7.34% |
| 2021 | -14.77 Million AUD | -189.4% |
| 2020 | -5.13 Million AUD | -54.83% |
| 2019 | -2.67 Million AUD | -17.28% |
| 2018 | -2.85 Million AUD | 9.23% |
| 2017 | -3.15 Million AUD | 34.25% |
| 2016 | -4.94 Million AUD | -990.96% |
| 2015 | -439.61 Thousand AUD | -66.93% |
| 2014 | -263.83 Thousand AUD | 7.93% |
| 2013 | -286.55 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | -26.75% |
| 2024 Q2 | -9.41 Million AUD | 0.0% |
| 2024 Q4 | -12.27 Million AUD | 0.0% |
| 2023 Q2 | -9.17 Million AUD | 0.0% |
| 2023 Q4 | -7.92 Million AUD | 0.0% |
| 2023 FY | - AUD | -22.53% |
| 2022 Q4 | -9.04 Million AUD | 0.0% |
| 2022 FY | - AUD | 7.34% |
| 2022 Q2 | -4.92 Million AUD | 0.0% |
| 2021 Q2 | -10.82 Million AUD | 0.0% |
| 2021 FY | - AUD | -189.4% |
| 2021 Q4 | -4.24 Million AUD | 0.0% |
| 2020 FY | - AUD | -54.83% |
| 2020 Q4 | -2.94 Million AUD | 0.0% |
| 2020 Q2 | -2.26 Million AUD | 0.0% |
| 2019 FY | - AUD | -17.28% |
| 2019 Q2 | -1 Million AUD | 0.0% |
| 2019 Q4 | -1.68 Million AUD | 0.0% |
| 2018 Q2 | -1 Million AUD | 0.0% |
| 2018 FY | - AUD | 9.23% |
| 2018 Q4 | -573.3 Thousand AUD | 0.0% |
| 2017 Q4 | -1.66 Million AUD | 0.0% |
| 2017 FY | - AUD | 34.25% |
| 2017 Q2 | -1.35 Million AUD | 0.0% |
| 2016 FY | - AUD | -990.96% |
| 2016 Q4 | -4.2 Million AUD | 0.0% |
| 2016 Q2 | -426.84 Thousand AUD | 0.0% |
| 2015 Q3 | - AUD | 100.0% |
| 2015 FY | - AUD | -66.93% |
| 2015 Q2 | -180.23 Thousand AUD | 0.0% |
| 2015 Q4 | -260.16 Thousand AUD | 0.0% |
| 2014 FY | - AUD | 7.93% |
| 2013 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 10.37 Million AUD | 305.813% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -1365.96% |
| Zelira Therapeutics Limited | -36.44 Million AUD | 41.401% |
| Biome Australia Limited | -1.57 Million AUD | -1253.023% |
| Patrys Limited | -3.49 Million AUD | -511.488% |
| Orthocell Limited | -11.68 Million AUD | -82.809% |
| Imugene Limited | -147.97 Million AUD | 85.569% |
| Noxopharm Limited | -5.94 Million AUD | -259.165% |
| PYC Therapeutics Limited | -38.11 Million AUD | 43.978% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | -88.978% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -197.175% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | -170.74% |
| Cynata Therapeutics Limited | -9.95 Million AUD | -114.61% |
| CSL Limited | 4.73 Billion AUD | 100.451% |
| Arovella Therapeutics Limited | -8.83 Million AUD | -141.749% |
| Bio-Gene Technology Limited | -2.97 Million AUD | -617.788% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 141.174% |
| Starpharma Holdings Limited | -12.57 Million AUD | -69.787% |
| Nanollose Limited | -1.14 Million AUD | -1760.274% |
| Memphasys Limited | -3.3 Million AUD | -545.584% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | -2864.033% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | -1088.793% |
| Amplia Therapeutics Limited | -4.55 Million AUD | -368.333% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | -53.413% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | -657.744% |
| Race Oncology Limited | -14.2 Million AUD | -50.345% |
| Nyrada Inc. | -4.59 Million AUD | -364.603% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 192.981% |
| Dimerix Limited | -24.95 Million AUD | 14.442% |
| PharmAust Limited | -9.45 Million AUD | -125.928% |
| Immutep Limited | -42.87 Million AUD | 50.195% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | 52.172% |
| Alterity Therapeutics Limited | -19.57 Million AUD | -9.108% |
| BTC Health Limited | 1.05 Million AUD | 2123.535% |
| Acrux Limited | -7.93 Million AUD | -169.249% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 110.717% |
| Biotron Limited | -5.04 Million AUD | -323.688% |
| Tissue Repair Ltd | -5.77 Million AUD | -269.768% |
| AdAlta Limited | -5.3 Million AUD | -302.702% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | 52.94% |
| Hexima Limited | -995.54 Thousand AUD | -2044.971% |
| AnteoTech Limited | -11.57 Million AUD | -84.549% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | 66.913% |
| Avecho Biotechnology Limited | -3.24 Million AUD | -558.567% |
| Actinogen Medical Limited | -12.92 Million AUD | -65.264% |
| Immuron Limited | -6.19 Million AUD | -244.846% |
| Argenica Therapeutics Limited | -1.89 Million AUD | -1025.327% |